General
Preferred name
NALORPHINE
Synonyms
Nalorphine hydrochloride ()
Nalorphine serb ()
Nalorfina ()
Nalorphine hydrochloride ciii ()
Nalorphine hcl ()
P&D ID
PD014720
CAS
97889-94-6
62-67-9
57-29-4
Tags
available
drug candidate
drug
Approved by
FDA
Drug indication
Discovery agent
Drug Status
vet_approved
approved
experimental
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
This drug does not have marketing approval in the US or European Union. Other national approval agencies may have granted marketing authorisation. In some countries nalorphine may only be used in veterinary practice.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
13
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
Guide to Pharmacology
NPC Screening Collection
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
30
Molecular Weight
311.15
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
5
Aromatic Ring Count
1
cLogP
1.75
TPSA
52.93
Fraction CSP3
0.47
Chiral centers
5.0
Largest ring
6.0
QED
0.82
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
